Unlabelled: Renal involvement in patients with COVID-19 ranges from proteinuria and hematuria to acute kidney injury (AKI). The occurrence of AKI range from 0.5% to 80% across various studies. Our study was conducted to know the renal manifestations of COVID-19 in south Indian population and its association with severity.

Material: The study assessed COVID-19 positive adult patients admitted from 1/9/2020 to 31/10/2020. Data was collected by accessing electronic medical records of patients. Proteinuria and hematuria were assessed by urine dipstick. Lab data including S. Creatinine at admission was accessed. S. Creatinine at a mean duration of 7±2, 14±4 days during hospitalization and on follow-up at a mean duration of 45 days after discharge was also captured.

Observation: A total of 1561 patients admitted during the study period were screened. After the exclusion criteria, 426 patients admitted with COVID-19 infection were enrolled. The occurrence of AKI was 14.8%. Proteinuria was positive in 75 patients (17.6%) hematuria in 39 patients (9.15 %). Patients with AKI, proteinuria and/or hematuria were more likely to have severe COVID-19 illness. 47.5% patients with AKI, 45.9 % with proteinuria and 34.4 % with hematuria had severe COVID-19 illness. The recovery of AKI at a mean duration of 45±15 days post discharge was 83.63 %.

Conclusion: Renal involvement is not uncommon in patients with COVID-19 infection especially in patients with severe illness. Presence of AKI, proteinuria and/or hematuria is associated with increased mortality among patients hospitalized with COVID-19 infection.

Download full-text PDF

Source

Publication Analysis

Top Keywords

patients
12
patients admitted
12
covid-19 infection
12
covid-19
9
renal manifestations
8
manifestations covid-19
8
renal involvement
8
patients covid-19
8
proteinuria hematuria
8
occurrence aki
8

Similar Publications

Background: Previously, we demonstrated that changes in circulating tumor DNA (ctDNA) are promising biomarkers for early response prediction (ERP) to immune checkpoint inhibitors (ICI) in metastatic urothelial cancer (mUC). In this study, we investigated the value of whole blood immunotranscriptomics for ERP-ICI and integrated both biomarkers into a multimodal model to boost accuracy.

Methods: Blood samples of 93 patients were collected at baseline and after 2-6 weeks of ICI for ctDNA (N=88) and immunotranscriptome (N=79) analyses.

View Article and Find Full Text PDF

Aerobic exercise prevents renal osteodystrophy via irisin-activated osteoblasts.

JCI Insight

January 2025

Department of Nephrology, Blood Purification Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.

Renal osteodystrophy is commonly seen in patients with chronic kidney disease (CKD) due to disrupted mineral homeostasis. Given the impaired renal function in these patients, common anti-resorptive agents, including bisphosphonates, must be used with caution or even contraindicated. Therefore, an alternative therapy without renal burden to combat renal osteodystrophy is urgently needed.

View Article and Find Full Text PDF

Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma.

J Clin Invest

January 2025

Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Metabolic reprogramming shapes tumor microenvironment (TME) and may lead to immunotherapy resistance in pancreatic ductal adenocarcinoma (PDAC). Elucidating the impact of pancreatic cancer cell metabolism in the TME is essential to therapeutic interventions. "Immune cold" PDAC is characterized by elevated lactate levels resulting from tumor cell metabolism, abundance of pro-tumor macrophages, and reduced cytotoxic T cell in the TME.

View Article and Find Full Text PDF

Background: Randomised controlled trials (RCTs) evaluating new systemic treatments for atopic dermatitis (AD) have increased dramatically over the last decade. These trials often incorporate topical therapies either as permitted concomitant or rescue treatments. Differential use of these topicals post-randomisation introduces potential bias as they may nullify or exaggerate treatment responses.

View Article and Find Full Text PDF

A model of care redesign within rheumatology: A mixed methods approach integrating nurse practitioners and physician assistants.

J Am Assoc Nurse Pract

January 2025

Division of Cardiology, Department of Medicine, Duke Health Integrated Practice, Duke University Health System, Durham, North Carolina.

Background: Increasing patient demand and clinician burnout in rheumatology practices have highlighted the need for more efficient models of care (MOC). Interprofessional collaboration is essential for improving patient outcomes and clinician satisfaction.

Local Problem: Our current MOC lacks standardization and formal integration of Nurse Practitioners (NPs) and Physician Assistants (PAs), resulting in reduced clinician satisfaction and limited patient access.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!